Promising results for Prana Biotechnology's Alzheimer's drug
Australian research company Prana Biotechnology has revealed successful interim results of its Alzheimer's drug PBT-1, Iodochlorhydroxyquin at the 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy in Geneva, Switzerland.